Company:  OMNICELL, INC (OMCL)
Form Type:  DEF 14A
Filing Date:  4/2/2018 
CIK:  0000926326 
Address:  590 E. MIDDLEFIELD ROAD 
City, State, Zip:  MOUNTAIN VIEW, California 94043 
Telephone:  (650) 251-6100 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$45.70  
Change: 
-0.15 (-0.33%)  
Trade Time: 
May 23  
Market Cap: 
$1.78B
Trade OMCL now with 

© 2018  
Description of Business
We are a leading provider of comprehensive automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. Our Automation and Analytics segment has more than 4,000 customers worldwide using our supply chain and analytics solutions to help enable them to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Our acquisition of Aesynt Holding, L.P., Aesynt, Ltd. and Aesynt Coöperatief U.A. (collectively, "Aesynt") in the first quarter of 2016 and the acquisition of Dixie Drawl, LLC d/b/a InPharmics ("InPharmics") in the second quarter of 2017 contribute to our distinct product capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry.
Register and access this filing in:     
  FORM DEF 14A
    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
    PROXY STATEMENT
    PROPOSAL NO. 1
      BENEFICIAL OWNERS
    Report of the Audit Committee of the Board of Directors(1)
    Compensation Committee Interlocks and Insider Participation
    PROPOSAL NO. 2
    PROPOSAL NO. 3
    ADVISORY VOTE ON EXECUTIVE COMPENSATION
    PROPOSAL NO. 4
      BENEFICIAL OWNERS
      BENEFICIAL OWNERS
      BENEFICIAL OWNERS
    Compensation Committee Report(1)
      COMPENSATION TABLE
      OPTIONS AGGREGATE
      NAME AND TITLE
    DIRECTOR COMPENSATION
    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
    OTHER MATTERS